Hepatitis B

US advisers scrap hepatitis B vaccine recommendation for most children

For infants of mothers who test negative, the panel recommended that parents, in consultation with a healthcare provider, should decide when or if their child will begin the vaccine series

WHO lauds Maldives for ending mother-to-child transmission of 3 diseases

Maldives becomes the first nation to achieve 'triple elimination' of mother-to-child transmission of HIV, syphilis and Hepatitis B

Trump questioned Hep B birth dose. Indian doctors say it's essential

Trump suggested delaying the Hep B vaccine, but Indian experts say the birth dose is proven safe, essential, and the best defence against mother-to-child infection in the country

Trump sparks row with unproven Tylenol-autism link, HepB vaccine scheduling

At White House press meet, Trump said Tylenol use in pregnancy may cause autism and also called for delaying Hep B vaccines; experts warn unproven claims risk fuelling confusion, vaccine hesitancy

World Hepatitis Day 2025: History, theme, measures, messages, quotes & more

Nobel laureate Dr. Baruch Blumberg discovered the Hepatitis B virus in 1967 and developed a vaccine for it. July 28 is marked as World Hepatitis Day to honor his birthday

World Hepatitis Day 2024: Everything to know about this infectious disease

World Hepatitis Day is observed annually on July 28 to raise awareness of this infectious disease and its impact on global health. The primary goal is to promote hepatitis prevention and show support

India second only to China in hepatitis B and C cases, says WHO report

India accounted for the second-highest number of cases of hepatitis B and C in 2022 after China, with 3.5 crore infections, according to a report by the World Health Organisation (WHO). Hepatitis is an inflammation of the liver that can cause a range of health problems and can be fatal. According to the WHO's 2024 Global Hepatitis Report released on Tuesday, 254 million people lived with hepatitis B and 50 million with hepatitis C in 2022 globally. India, which was second only to China in the viral hepatitis burden, registered 2.98 crore hepatitis B cases in 2022 while the number of hepatitis C infections stood at 55 lakh. China registered 8.3 crore cases of hepatitis B and C, representing 27.5 per cent of the total disease burden. The report said that with a total of 3.5 crore cases, India accounted for 11.6 per cent of the total disease burden globally that year. There are five main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause live

World Hepatitis Day 2023: History, significance, symptoms and more

World Hepatitis Day aims to raise awareness about viral hepatitis and finding ways to prevent, test and treat the disease. Reports say someone dies every 30 seconds globally due to hepatitis

Hepatitis A outbreak in Guwahati; Assam CM Sarma inspects water quality

While widespread screening is being conducted, health department representatives informed that 37 people have tested positive for hepatitis A virus in North Guwahati

3-dose hepatitis B vaccine fully protects HIV positive adults: Study

Three doses of HEPLISAV-B vaccine provide full protection to adults with HIV, who were never immunised against hepatitis B virus (HBV) either through vaccination or infection, according to a study. In the research presented at the annual IDWeek conference held in Washington, US from October 19 to 23, the researchers from University of Cincinnati and Cornell University tested the three-dose course of HEPLISAV-B among 68 adults living with HIV at 38 sites in the US, South Africa, and Thailand. None of the participants had either received a previous HBV vaccination or had evidence of a previous HBV infection - all were on antiretroviral therapy to combat infection by retroviruses such as HIV. Retroviruses are a group of viruses that contain two single-strand linear RNA molecules per virion, or a viral particle, and reverse transcriptase (RNA to DNA). Following the initial dose of HEPLISAV-B vaccine 0.5 milliliter (mL) as an intramuscular injection, the study participants received ...

Health officials probing mysterious rise in cases of hepatitis in children

Health officials around the world are investigating a mysterious increase in cases of the liver condition which was first spotted in the UK

NTAGI meet this week to review vaccine data for 5-12 age group

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

Hepatitis outbreak in children: Adenovirus type 41, a possible culprit

A recent spate of severe liver inflammation (hepatitis) has been reported in previously healthy children. As of April 21, there have been 169 confirmed cases of acute hepatitis of unknown origin

Hepatitis B: Know about this silent killer's symptoms, treatment and cure

What is Hepatitis B, what are its symptoms, treatment and how to prevent Hepatitis B - these are some of the questions we'll be answering

Laurus Labs transfers ownership rights of hepatitis B drug to CASI Pharma

BS ReporterHyderabad, 23 October: Hyderabad-based Laurus Labs Limited today announced that it has transferred an abbreviated new drug application(ANDA) of Tenofovir Disoproxil Fumarate (TDF) to Nasdaq-listed biopharmaceutical company CASI Pharmaceuticals for use in China, in exchange for certain up-front and milestone payments. Laurus Lab's new drug application of TDF was approved by the US Food and Drug Administration(US FDA).TDF is prescribed for the treatment of Hepatitis B virus(HBV) infection. China is expected to have more than 90 million chronic carriers of hepatitis B, roughly one-third of all HBV cases in the world. TDF is used as the first line of therapy."The transfer of TDF ANDA for its use in China enhances our strategic focus to leverage our development and manufacturing capabilities in the markets where we have little presence. Partnering with CASI Pharmaceuticals, in particular, would enable Laurus Labs to monetise its asset in China while building a robust pipeline ...